Drosophila as a model to study the genetic mechanisms of obesity-associated heart dysfunction

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 966-971

  Diop, Soda Balla ^a   Bodmer, Rolf ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Genetic control; Heart dysfunction; Obesity; Triglycerides

Indexed keywords

ANIMAL; DISEASE MODEL; DROSOPHILA MELANOGASTER; GENETICS; HEART DISEASE; LIPID DIET; OBESITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HEART DISEASES; OBESITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84860350761     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01522.x     Document Type: Review

References (46)

1. Hunziker W, Kiener TK, Xu J. Vertebrate animal models unravel physiological roles for zonula occludens tight junction adaptor proteins. Ann N Y Acad Sci. 2009; 1165: 28-33.
2. Burggren WW, Warburton S. Amphibians as animal models for laboratory research in physiology. ILAR J. 2007; 48: 260-9.
3. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007; 8: 353-67.
4. Chianese R, Chioccarelli T, Cacciola G, et al. The contribution of lower vertebrate animal models in human reproduction research. Gen Comp Endocrinol. 2011; 171: 17-27.
5. Botstein D, Chervitz SA, Cherry JM. Yeast as a model organism. Science. 1997; 277: 1259-60.
6. Brumby AM, Richardson HE. Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer. 2005; 5: 626-39.
7. Kaletta T, Hengartner MO. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov. 2006; 5: 387-98.
8. Segalat L. Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol. 2007; 2: 231-6.
9. Pandey UB, Nichols CD. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev. 2011; 63: 411-36.
10. Bier E, Bodmer R. Drosophila, an emerging model for cardiac disease. Gene. 2004; 342: 1-11.
11. Ocorr K, Perrin L, Lim HY, et al. Genetic control of heart function and aging in Drosophila. Trends Cardiovasc Med. 2007; 17: 177-82.
12. Reiter LT, Potocki L, Chien S, et al. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001; 11: 1114-25.
13. Bodmer R. Heart development in Drosophila and its relationship to vertebrate systems. Trends Cardiovasc Med. 1995; 5: 21-7.
14. Rizki TM. The Circulatory System and Associated Cells and Tissues in the Genetics and Biology of Drosophila. New York: Academic Press; 1978. 397-452.
15. Cammarato A, Ahrens CH, Alayari NN, et al. A mighty small heart: the cardiac proteome of adult Drosophila melanogaster. PLoS ONE. 2011; 6: e18497.
16. Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in Drosophila. Development. 1993; 118: 719-29.
17. Lyons I, Parsons LM, Hartley L, et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 1995; 9: 1654-66.
18. Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998; 281: 108-11.
19. Satou Y, Satoh N. Gene regulatory networks for the development and evolution of the chordate heart. Genes Dev. 2006; 20: 2634-8.
20. Kim SK, Rulifson EJ. Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells. Nature. 2004; 431: 316-20.
21. Baker KD, Thummel CS. Diabetic larvae and obese flies-emerging studies of metabolism in Drosophila. Cell Metab. 2007; 6: 257-66.
22. Broughton SJ, Piper MD, Ikeya T, et al. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc Natl Acad Sci USA. 2005; 102: 3105-10.
23. Gade G, Auerswald L. Mode of action of neuropeptides from the adipokinetic hormone family. Gen Comp Endocrinol. 2003; 132: 10-20.
24. Noyes BE, Katz FN, Schaffer MH. Identification and expression of the Drosophila adipokinetic hormone gene. Mol Cell Endocrinol. 1995; 109: 133-41.
25. Lee G, Park JH. Hemolymph sugar homeostasis and starvation-induced hyperactivity affected by genetic manipulations of the adipokinetic hormone-encoding gene in Drosophila melanogaster. Genetics. 2004; 167: 311-23.
26. Isabel G, Martin JR, Chidami S, et al. AKH-producing neuroendocrine cell ablation decreases trehalose and induces behavioral changes in Drosophila. Am J Physiol Regul Integr Comp Physiol. 2005; 288: R531-8.
27. Colombani J, Raisin S, Pantalacci S, et al.A nutrient sensor mechanism controls Drosophila growth. Cell. 2003; 114: 739-49.
28. Birse R, Choi J, Reardon K, et al. High fat diet-induced obesity and heart dysfunction is regulated by the TOR pathway in the Drosophila model. Cell Metab. 2010; 12: 533-44.
29. Musselman LP, Fink JL, Narzinski K, et al.A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila. Dis Model Mech. 2011; 4: 842-9.
30. Crepaldi G, Maggi, S. The metabolic syndrome: a historical context. Diabetes Voice. 2006; 51: 8-10.
31. Fink M, Callol-Massot C, Chu A, et al. A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts. BioTechniques. 2009; 46: 101-13.
32. Lee JH, Budanov AV, Park EJ, et al. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science. 2010; 327: 1223-8.
33. Lim HY, Wang W, Wessells RJ, et al. Phospholipid homeostasis regulates lipid metabolism and cardiac function through SREBP signaling in Drosophila. Genes Dev. 2011; 25: 189-200.
34. Kunte AS, Matthews KA, Rawson RB. Fatty acid auxotrophy in Drosophila larvae lacking SREBP. Cell Metab. 2006; 3: 439-48.
35. Peterson TR, Sengupta SS, Harris TE, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011; 146: 408-20.
36. Puigserver P, Wu Z, Park CW, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998; 92: 829-39.
37. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 2000; 20: 1868-76.
38. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev. 2003; 24: 78-90.
39. Wang YX, Zhang CL, Yu RT, et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2004; 2: e294.
40. Lin J, Wu PH, Tarr PT, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell. 2004; 119: 121-35.
41. Lustig Y, Ruas JL, Estall JL, et al. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. Genes Dev. 2011; 25: 1232-44.
42. Lehman JJ, Barger PM, Kovacs A, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000; 106: 847-56.
43. Schilling J, Kelly DP. The PGC-1 cascade as a therapeutic target for heart failure. J Mol Cell Cardiol. 2011; 51: 578-83.
44. Lai L, Leone TC, Zechner C, et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 2008; 22: 1948-61.
45. Gershman B, Puig O, Hang L, et al. High-resolution dynamics of the transcriptional response to nutrition in Drosophila: a key role for dFOXO. Physiol Genomics. 2007; 29: 24-34.
46. Tiefenbock SK, Baltzer C, Egli NA, et al. The Drosophila PGC-1 homologue Spargel coordinates mitochondrial activity to insulin signalling. EMBO J. 2010; 29: 171-83.